Steven M. Grunberg

13.7k citations

156 papers · 9.9k indexed · 4 hit papers · h-index 50

Surgery top 0.2%
Physiology top 0.5%
Oncology top 1%
Pulmonary and Respiratory Medicine top 1%
Molecular Biology top 10%

Co-authors: Paul J. Hesketh Richard J. Gralla Mark G. Kris William A. Haseltine Matti Aapro W. David Henner Kevin Horgan James M. Koeller
Topics: Nausea and vomiting management (90 papers)Anesthesia and Pain Management (52 papers)Pathogenesis and Treatment of Hiccups (25 papers)
Cited by: Surgery Anesthesiology and Pain Medicine Physiology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Italy Denmark

In The Last Decade

Steven M. Grunberg

155 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations

2008 661 citations Steven M. Grunberg et al. Journal of Clinical Oncology profile →
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

2003 593 citations Paul J. Hesketh, Steven M. Grunberg et al. Journal of Clinical Oncology profile →
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006

2006 516 citations Mark G. Kris, Paul J. Hesketh et al. Journal of Clinical Oncology profile →
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

1999 483 citations Richard J. Gralla, Mark G. Kris et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Steven M. Grunberg

Since Specialization

Citations

This map shows the geographic impact of Steven M. Grunberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Grunberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Grunberg more than expected).

Fields of papers citing papers by Steven M. Grunberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Grunberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Grunberg. The network helps show where Steven M. Grunberg may publish in the future.

Co-authorship network of co-authors of Steven M. Grunberg

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Grunberg. A scholar is included among the top collaborators of Steven M. Grunberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Grunberg. Steven M. Grunberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force 2014 ·Annals of Oncology ·Matti Aapro,Jann Arends,Federico Bozzetti,K.C.H. Fearon,Steven M. Grunberg,Jørn Herrstedt,Jane B. Hopkinson,N. Jacquelin-Ravel,Aminah Jatoi,S. Kaasa,Florian Strasser	231
2	A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy 2014 ·Annals of Oncology ·Matti Aapro,H. S. Rugo,Antônio Rossi,Giada Rizzi,Maria Elisa Borroni,Igor Bondarenko,Tomasz Sarosiek,Cristina Oprean,Servando Cardona‐Huerta,Vito Lorusso,(unknown),Lee S. Schwartzberg,Steven M. Grunberg	180
3	Emerging treatments in chemotherapy-induced nausea and vomiting. 2013 ·PubMed ·Steven M. Grunberg,Barbara S. Slusher,Hope S. Rugo	20
4	Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement 2013 ·The Breast ·Fátima Cardoso,Nuran Beşe,Sandra R. Distelhorst,José Luiz Barbosa Bevilacqua,Ophira Ginsburg,Steven M. Grunberg,Richard J. Gralla,(unknown),Olivia Pagani,Ann H. Partridge,Felícia Marie Knaul,Matti Aapro,Barbara L. Andersen,Beti Thompson,Julie R. Gralow,Benjamin O. Anderson	53
5	Cost–Utility Analysis of Palonosetron-Based Therapy in Preventing Emesis Among Breast Cancer Patients 2010 ·PubMed ·Elenir B.C. Avritscher,Ya‐Chen Tina Shih,Charlotte C. Sun,Richard J. Gralla,Steven M. Grunberg,Ying Xu,Linda S. Elting	16
6	Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy 2010 ·Supportive Care in Cancer ·Mark G. Kris,Maurizio Tonato,Emilio Bria,Enzo Ballatori,B.T. Espersen,Jørn Herrstedt,Cynthia N. Rittenberg,Lawrence H. Einhorn,Steven M. Grunberg,Mitsue Saito,Gary R. Morrow,Paul J. Hesketh	27
7	Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting 2009 ·Annals of Oncology ·Fausto Roila,Janusz Rolski,Rodryg Ramlau,Mircea Dediu,Mark W. Russo,Rajesh Bandekar,Steven M. Grunberg	27
8	Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis 2006 ·Annals of Oncology ·Steven M. Grunberg	112
9	Management of patients receiving long-term treatment with mifepristone 2005 ·Fertility and Sterility ·Irving M. Spitz,Steven M. Grunberg,Nathalie Chabbert‐Buffet,(unknown),(unknown),Régine Sitruk‐Ware	48
10	Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement 2004 ·Supportive Care in Cancer ·Lawrence H. Einhorn,Bernardo L. Rapoport,Jim M. Koeller,Steven M. Grunberg,Petra Feyer,Cynthia N. Rittenberg,Matti Aapro	26
11	Establishing the dose of the oral NK₁ antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting 2003 ·Cancer ·Sant P. Chawla,Steven M. Grunberg,Richard J. Gralla,Paul J. Hesketh,(unknown),M. Elmer,(unknown),Arlene Taylor,Alexandra D. Carides,Judith K. Evans,Kevin Horgan	177
12	Unresectable Primary and Recurrent Head and Neck Tumors: Effect of Hyperthermia and Carboplatin—Preliminary Experience 2000 ·Radiology ·(unknown),Michael D. Sapozink,Steven M. Grunberg,Gabor Jozsef,(unknown),Silvia C. Formenti,Oscar E. Streeter	4
13	Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study 1999 ·Cancer Chemotherapy and Pharmacology ·Steven M. Grunberg,John Crowley,Kenneth R. Hande,Dori Giroux,Nikhil C. Munshi,Derick Lau,Louis E. Schroder,(unknown),Stanley P. Balcerzak,Harry E. Hynes,David R. Gandara	15
14	Innovative approaches in the treatment of emesis 1997 ·Supportive Care in Cancer ·Steven M. Grunberg	4
15	Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. 1993 ·Journal of Clinical Oncology ·Steven M. Grunberg,John Crowley,Robert B. Livingston,(unknown),Stephen K. Williamson,Timothy J. O’Rourke,T. Braun,M. Ernest Marshall,James K. Weick,S P Balcerzak	9
16	The role of progesterone receptors in meningioma 1992 ·Cancer treatment and research ·Steven M. Grunberg	12
17	Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry 1991 ·Carcinogenesis ·R. J. Parker,(unknown),Robert E. Tarone,Justine Vionnet,Steven M. Grunberg,Franco M. Muggia,Eddie Reed	66
18	Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone 1991 ·Journal of neurosurgery ·Steven M. Grunberg,Martin H. Weiss,Irving M. Spitz,Jamshid Ahmadi,Alfredo A. Sadun,Christy Russell,Lúcia Míriam Dumont Lucci,(unknown)	294
19	Phase II Evaluation of Recombinant Interferon-β (LFN-β _ser ) in Patients with Diffuse Mesothelioma: A Southwest Oncology Group Study 1990 ·Journal of Interferon Research ·Daniel D. Von Hoff,Barbara Metch,Joel G. Lucas,Stanley P. Balcerzak,Steven M. Grunberg,Saul E. Rivkin	37
20	Progressive paresthesias after cessation of therapy with very high-dose cisplatin 1989 ·Cancer Chemotherapy and Pharmacology ·Steven M. Grunberg,(unknown),(unknown),Franco M. Muggia	67

About Steven M. Grunberg

Steven M. Grunberg is a scholar working on Surgery, Otorhinolaryngology and Oncology, having authored 156 papers that have together received 9.9k indexed citations. Recurring topics across this work include Nausea and vomiting management (90 papers), Anesthesia and Pain Management (52 papers) and Pathogenesis and Treatment of Hiccups (25 papers). The work is most often cited by research in Surgery (5.8k citations), Anesthesiology and Pain Medicine (719 citations) and Physiology (3.1k citations). Steven M. Grunberg has collaborated with scholars based in United States, Italy and Denmark. Frequent co-authors include Paul J. Hesketh, Richard J. Gralla, Mark G. Kris, William A. Haseltine, Matti Aapro, W. David Henner, Kevin Horgan, James M. Koeller, Alexandra D. Carides and Jørn Herrstedt. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact